Print Page      Close Window     

Investors

SEC Filings

6-K
OBSEVA SA filed this Form 6-K on 03/30/2018
Entire Document
 


LOGO

 

Unique mix of clinical and operational experience provides in-depth understanding of patient & physician needs Ernest Loumaye, MD, PhD, OB/GYN CEO and Co-founder Tim Adams CFO Jean-Pierre Gotteland, PhD CSO Elke Bestel, MD CMO Ben T.G. Tan, MSc VP Commercial & BD A team of 35+ based in Geneva and Boston, with successful experience in world-wide development and commercialization of women health products ObsEva is listed on The NASDAQ Global Select Market and trades under the ticker symbol “OBSV”